Cancer BiologyCancer ResearchPeer-reviewed
Adaptive therapy achieves long-term control of chemotherapy resistance in high grade ovarian cancer
Helen Hockings, Eszter Lakatos, Weini Huang…·Michelle Lockley
This study demonstrates that adaptive therapy reduces chemotherapy resistance in ovarian cancer by exploiting fitness costs of resistant cells, extending survival in mice and correlating with disease burden in patients.